Parmax Pharma Board Approves Unaudited Financial Results

Parmax Pharma Ltd announced that its Board of Directors, in a meeting held on August 14, 2026, approved the unaudited financial results for the quarter ended June 30, 2026. The board also approved the appointment of Mr. Dhiren Chandulal Shah as Additional Director – Non-Executive and Chairman, and Mr. Sunil Shah as Additional Director - Non-Executive. Additionally, the appointment of Mrs. Anjana Paresh Shah and Mr. Ashish Atmaram Shah as Non-Executive Independent Directors for 5 years was recommended for the upcoming AGM. Ms. Salma Thobhani resigned as a non-executive director.